Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial.

Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams LS.

Stroke. 2008 Feb;39(2):384-9. Epub 2007 Dec 20.

2.

Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia.

Staszewski J, Brodacki B, Kotowicz J, Stepien A.

J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):150-4. doi: 10.1016/j.jstrokecerebrovasdis.2009.11.013. Epub 2010 Jul 10.

PMID:
20621520
3.

Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial.

Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR; GRASP Investigators.

Stroke. 2009 Dec;40(12):3804-9. doi: 10.1161/STROKEAHA.109.561498. Epub 2009 Oct 15.

4.

The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke.

Bruno A, Durkalski VL, Hall CE, Juneja R, Barsan WG, Janis S, Meurer WJ, Fansler A, Johnston KC; SHINE investigators.

Int J Stroke. 2014 Feb;9(2):246-51. doi: 10.1111/ijs.12045. Epub 2013 Mar 19.

5.
6.

Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment.

Kreisel SH, Berschin UM, Hammes HP, Leweling H, Bertsch T, Hennerici MG, Schwarz S.

Cerebrovasc Dis. 2009;27(2):167-75. doi: 10.1159/000185608. Epub 2008 Dec 18.

PMID:
19092238
7.

Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial.

Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S, Deltour S, Multlu G, Leger A, Meresse I, Payan C, Dormont D, Samson Y.

Stroke. 2012 Sep;43(9):2343-9. doi: 10.1161/STROKEAHA.112.657122. Epub 2012 Jun 14.

8.

Lowering of glucose in critical care: a randomized pilot trial.

McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D, Leppert R, Foss A, Cook D.

J Crit Care. 2007 Jun;22(2):112-8; discussion 118-9. Epub 2007 Jan 31.

PMID:
17548021
9.

Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome.

Fuentes B, Ortega-Casarrubios MA, Sanjosé B, Castillo J, Leira R, Serena J, Vivancos J, Dávalos A, Gil-Nuñez A, Egido J, Díez-Tejedor E; Stroke Project of the Cerebrovascular Diseases Study Group Spanish Society of Neurology.

Stroke. 2010 Oct;41(10):2362-5. doi: 10.1161/STROKEAHA.110.591529. Epub 2010 Aug 19.

10.

Persistent hyperglycemia at 24-48 h in acute hyperglycemic stroke patients is not associated with a worse functional outcome.

Ntaios G, Abatzi C, Alexandrou M, Lambrou D, Chatzopoulos S, Egli M, Ruiz J, Bornstein N, Michel P.

Cerebrovasc Dis. 2011;32(6):561-6. doi: 10.1159/000331924. Epub 2011 Nov 18.

PMID:
22104640
11.

Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.

de Mulder M, Umans VA, Cornel JH, van der Zant FM, Stam F, Oemrawsingh RM, Akkerhuis KM, Boersma E.

JAMA Intern Med. 2013 Nov 11;173(20):1896-904. doi: 10.1001/jamainternmed.2013.10074.

PMID:
24018647
12.

Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.

Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H.

Ann Surg. 2011 Sep;254(3):458-63; discussion 463-4. doi: 10.1097/SLA.0b013e31822c5d78.

PMID:
21865944
13.
14.

The efficacy and safety of glucose control algorithms in intensive care: a pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial.

Henderson WR, Dhingra V, Chittock D, Foster D, Hebert P, Cook D, Heyland D, Dodek P, Griesdale D, Schulzer M, Ronco JJ; Canadian Critical Trials Group.

Pol Arch Med Wewn. 2009 Jul-Aug;119(7-8):439-46.

15.

Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach.

Ramos P, Childers D, Maynard G, Box K, Namba J, Stadalman K, Renvall M.

J Hosp Med. 2010 Oct;5(8):446-51. doi: 10.1002/jhm.810.

PMID:
20945469
16.

Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia.

Nardi K, Milia P, Eusebi P, Paciaroni M, Caso V, Agnelli G.

J Diabetes Complications. 2012 Mar-Apr;26(2):70-6. doi: 10.1016/j.jdiacomp.2012.03.001. Epub 2012 Apr 10.

PMID:
22494837
17.

Glucose control in acute myocardial infarction: a pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care.

Sampaio CR, Franco DR, Goldberg DJ, Baptista J, Eliaschewitz FG.

Diabetes Technol Ther. 2012 Feb;14(2):117-24. doi: 10.1089/dia.2011.0157. Epub 2011 Dec 19.

PMID:
22181063
18.

Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, Quintana M, Alvarez-Sabín J.

Stroke. 2005 Aug;36(8):1705-9. Epub 2005 Jul 7.

19.

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

Anderson JH Jr, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R.

Arch Intern Med. 1997 Jun 9;157(11):1249-55.

PMID:
9183237
20.

Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.

Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, Bogle A, Iqbal N, List J, Griffen SC.

Diabetes Care. 2015 Mar;38(3):412-9. doi: 10.2337/dc13-2955. Epub 2014 Sep 30.

PMID:
25271207

Supplemental Content

Support Center